The alarm pheromone in male rats as a unique anxiety model: Psychopharmacological evidence using anxiolytics

Pharmacology Biochemistry and Behavior

Volumn 94, Issue 4, 2010, Pages 575-579

  Inagaki, Hideaki ^a   Kiyokawa, Yasushi ^a,b   Takeuchi, Yukari ^a   Mori, Yuji ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b JAPAN SOCIETY FOR THE PROMOTION OF SCIENCE   (Japan)

Author keywords

Acoustic startle reflex; Alarm pheromone; Animal model; Anxiety; Anxiolytic; Predictive validity; Rat

Indexed keywords

BUSPIRONE; BUTYL[2,5 DIMETHYL 7 (2,4,6 TRIMETHYLPHENYL) 7H PYRROLO[2,3 D]PYRIMIDIN 4 YL]ETHYLAMINE; CLONIDINE; MIDAZOLAM; PHENELZINE; PHEROMONE; PROPRANOLOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY DISORDER; ARTICLE; CONTROLLED STUDY; DISEASE MODEL; DOSE RESPONSE; DRUG MECHANISM; EXPERIMENTAL RAT; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TRANQUILIZING ACTIVITY;

ADMINISTRATION, INHALATION; ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; BUSPIRONE; CLONIDINE; DISEASE MODELS, ANIMAL; MALE; MIDAZOLAM; PHENELZINE; PHEROMONES; PROPRANOLOL; PYRIMIDINES; PYRROLES; RATS; RATS, WISTAR; STARTLE REACTION;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

EID: 74249109968     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2009.11.013     Document Type: Article

References (49)

1. Baldwin D.S., Anderson I.M., Nutt D.J., Bandelow B., Bond A., Davidson J.R.T., et al. Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology. J Psychopharmacol 19 (2005) 567-596
2. Bandelow B., Zohar J., Hollander E., Kasper S., Moller H.J., Allgulander C., et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision. World J Biol Psychiatry 9 (2008) 248-312
3. Belzung C., and Griebel G. Measuring normal and pathological anxiety-like behaviour in mice: a review. Behav Brain Res 125 (2001) 141-149
4. Bienvenu O.J., and Ginsburg G.S. Prevention of anxiety disorders. Int Rev Psychiatry 19 (2007) 647-654
5. Blanchard D.C., Griebel G., and Blanchard R.J. Conditioning and residual emotionality effects of predator stimuli: some reflections on stress and emotion. Prog Neuropsychopharmacol Biol Psychiatry 27 (2003) 1177-1185
6. Bodnoff S.R., Suranyi-Cadotte B., Quirion R., and Meaney M.J. A comparison of the effects of diazepam versus several typical and atypical anti-depressant drugs in an animal model of anxiety. Psychopharmacology (Berl) 97 (1989) 277-279
7. Bristow L.J., O'Connor D., Watts R., Duxon M.S., and Hutson P.H. Evidence for accelerated desensitisation of 5-HT2C receptors following combined treatment with fluoxetine and the 5-HT1A receptor antagonist, WAY 100, 635, in the rat. Neuropharmacology 39 (2000) 1222-1236
8. Dielenberg R.A., and McGregor I.S. Defensive behavior in rats towards predatory odors: a review. Neurosci Biobehav Rev 25 (2001) 597-609
9. 1A receptor agonists and NMDA receptor antagonists in the social interaction test and the elevated plus maze. Eur J Pharmacol 169 (1989) 1-10
10. Durand M., Berton O., Aguerre S., Edno L., Combourieu I., Mormede P., et al. Effects of repeated fluoxetine on anxiety-related behaviours, central serotonergic systems, and the corticotropic axis in SHR and WKY rats. Neuropharmacology 38 (1999) 893-907
11. 1A receptor antagonist WAY100635. Br J Pharmacol 130 (2000) 1713-1719
12. Fendt M., Endres T., Lowry C.A., Apfelbach R., and McGregor I.S. TMT-induced autonomic and behavioral changes and the neural basis of its processing. Neurosci Biobehav Rev 29 (2005) 1145-1156
13. Fernandez-Guasti A., Reyes R., Martinez-Mota L., and Lopez-Munoz F.J. Influence of inflammatory nociception on the anxiolytic-like effect of diazepam and buspirone in rats. Psychopharmacology 180 (2005) 399-407
14. 1A receptor function. Pharmacol Biochem Behav 62 (1999) 695-701
15. Graeff F.G., Netto C.F., and Zangrossi H. The elevated T-maze as an experimental model of anxiety. Neurosci Biobehav Rev 23 (1998) 237-246
16. Griebel G., Cohen C., Perrault G., and Sanger D.J. Behavioral effects of acute and chronic fluoxetine in Wistar-Kyoto rats. Physiol Behav 67 (1999) 315-320
17. Grillon C., Pellowski M., Merikangas K.R., and Davis M. Darkness facilitates the acoustic startle reflex in humans. Biol Psychiatry 42 (1997) 453-460
18. Iijima M., and Chaki S. Separation-induced ultrasonic vocalization in rat pups: further pharmacological characterization. Pharmacol Biochem Behav 82 (2005) 652-657
19. Inagaki H., Kiyokawa Y., Kikusui T., Takeuchi Y., and Mori Y. Enhancement of the acoustic startle reflex by an alarm pheromone in male rats. Physiol Behav 93 (2008) 606-611
20. Inagaki H., Nakamura K., Kiyokawa Y., Kikusui T., Takeuchi Y., and Mori Y. The volatility of an alarm pheromone in male rats. Physiol Behav 96 (2009) 749-752
21. Kikusui T., Takigami S., Takeuchi Y., and Mori Y. Alarm pheromone enhances stress-induced hyperthermia in rats. Physiol Behav 72 (2001) 45-50
22. Kiyokawa Y., Kikusui T., Takeuchi Y., and Mori Y. Modulatory role of testosterone in alarm pheromone release by male rats. Horm Behav 45 (2004) 122-127
23. Kiyokawa Y., Kikusui T., Takeuchi Y., and Mori Y. Alarm pheromones with different functions are released from different regions of the body surface of male rats. Chem Senses 29 (2004) 35-40
24. Kiyokawa Y., Kikusui T., Takeuchi Y., and Mori Y. Alarm pheromone that aggravates stress-induced hyperthermia is soluble in water. Chem Senses 30 (2005) 513-519
25. Kiyokawa Y., Kikusui T., Takeuchi Y., and Mori Y. Mapping the neural circuit activated by alarm pheromone perception by c-Fos immunohistochemistry. Brain Res 1043 (2005) 145-154
26. Kiyokawa Y., Kikusui T., Takeuchi Y., and Mori Y. Removal of the vomeronasal organ blocks the stress-induced hyperthermia response to alarm pheromone in male rats. Chem Senses 32 (2007) 57-64
27. Kiyokawa Y., Shimozuru M., Kikusui T., Takeuchi Y., and Mori Y. Alarm pheromone increases defensive and risk assessment behaviors in male rats. Physiol Behav 87 (2006) 383-387
28. Kshama D., Hrishikeshavan H.J., Shanbhogue R., and Munonyedi U.S. Modulation of baseline behavior in rats by putative serotonergic agents in three ethoexperimental paradigms. Behav Neural Biol 54 (1990) 234-253
29. Li X.B., Inoue T., Hashimoto S., and Koyama T. Effect of chronic administration of flesinoxan and fluvoxamine on freezing behavior induced by conditioned fear. Eur J Pharmacol 425 (2001) 43-50
30. Lopez-Rubalcava C., Cruz S.L., and Fernandez-Guasti A. Blockade of the anxiolytic-like action of ipsapirone and buspirone, but not that of 8-OH-DPAT, by adrenalectomy in male rats. Psychoneuroendocrinology 24 (1999) 409-422
31. Lorrain D.S., Baccei C.S., Correa L.D., and Bristow L.J. Comparison of the effects of diazepam, the CRF1 antagonist CP-154, 526 and the group II mGlu receptor agonist LY379268 on stress-evoked extracellular norepinephrine levels. Neuropharmacology 48 (2005) 927-935
32. Louis C., Stemmelin J., Boulay D., Bergis O., Cohen C., and Griebel G. Additional evidence for anxiolytic- and antidepressant-like activities of saredutant (SR48968), an antagonist at the neurokinin-2 receptor in various rodent-models. Pharmacol Biochem Behav 89 (2008) 36-45
33. Ludewig S., Geyer M.A., Ramseier M., Vollenweider F.X., Rechsteiner E., and Cattapan-Ludewig K. Information-processing deficits and cognitive dysfunction in panic disorder. J Psychiatry Neurosci 30 (2005) 37-43
34. McGregor I.S., Schrama L., Ambermoon P., and Dielenberg R.A. Not all 'predator odours' are equal: cat odour but not 2, 4, 5 trimethylthiazoline (TMT; fox odour) elicits specific defensive behaviours in rats. Behav Brain Res 129 (2002) 1-16
35. McGregor I.S., Hargreaves G.A., Apfelbach R., and Hunt G.E. Neural correlates of cat odor-induced anxiety in rats: region-specific effects of the benzodiazepine midazolam. J Neurosci 24 (2004) 4134-4144
36. Olivier B., Molewijk H.E., van der Heyden J.A.M., van Oorschot R., Ronken E., Mos J., et al. Ultrasonic vocalizations in rat pups: effects of serotonergic ligands. Neurosci Biobehav Rev 23 (1998) 215-227
37. Paslawski T., Treit D., Baker G.B., George M., and Coutts R.T. The antidepressant drug phenelzine produces antianxiety effects in the plus-maze and increases in rat brain GABA. Psychopharmacology 127 (1996) 19-24
38. Poltronieri S.C., Zangrossi H., and Viana M.D. Antipanic-like effect of serotonin reuptake inhibitors in the elevated T-maze. Behav Brain Res 147 (2003) 185-192
39. Prehn A., Ohrt A., Sojka B., Ferstl R., and Pause B.M. Chemosensory anxiety signals augment the startle reflex in humans. Neurosci Lett 394 (2006) 127-130
40. Rauch S.L., Whalen P.J., Shin L.M., McInerney S.C., Macklin M.L., Lasko N.B., et al. Exaggerated amygdala response to masked facial stimuli in posttraumatic stress disorder: a functional MRI study. Biol Psychiatry 47 (2000) 769-776
41. Sanchez C., and Meier E. Behavioral profiles of SSRIs in animal models of depression, anxiety and aggression. Are they all alike?. Psychopharmacology (Berl) 129 (1997) 197-205
42. Sher K.J., and Trull T.J. Methodological issues in psychopathology research. Annu Rev Psychol 47 (1996) 371-400
43. Silva R.C., and Brandao M.L. Acute and chronic effects of gepirone and fluoxetine in rats tested in the elevated plus-maze: an ethological analysis. Pharmacol Biochem Behav 65 (2000) 209-216
44. Soderpalm B., and Engel J.A. Biphasic effects of clonidine on conflict behavior: involvement of different alpha-adrenoceptors. Pharmacol Biochem Behav 30 (1988) 471-477
45. Staples L.G., McGgregor I.S., Apfelbach R., and Hunt G.E. Cat odor, but not trimethylthiazoline (fox odor), activates accessory olfactory and defense-related brain regions in rats. Neuroscience 151 (2008) 937-947
46. Stein M.B., Simmons A.N., Feinstein J.S., and Paulus M.P. Increased amygdala and insula activation during emotion processing in anxiety-prone subjects. Am J Psychiatry 164 (2007) 318-327
47. To C.T., Anheuer Z.E., and Bagdy G. Effects of acute and chronic fluoxetine treatment of CRH-induced anxiety. Neuroreport 10 (1999) 553-555
48. Walker D.L., and Davis M. Anxiogenic effects of high illumination levels assessed with the acoustic startle response in rats. Biol Psychiatry 42 (1997) 461-471
49. Walker D.L., and Davis M. Light-enhanced startle: further pharmacological and behavioral characterization. Psychopharmacology 159 (2002) 304-310